Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Bromobuterol is a bronchodilator used primarily for the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Structurally, it is a derivative of buterol, modified to enhance its efficacy in relaxing and opening air passages in the lungs, thereby facilitating easier breathing. The gene location and specific molecular structure of bromobuterol are designed to target beta2-adrenergic receptors, similar to other bronchodilators like albuterol, but with modifications that may improve its selectivity and duration of action. Functionally, bromobuterol works by stimulating these receptors, leading to muscle relaxation in the airways and improved airflow. This mechanism is crucial for patients with obstructive airway conditions, providing relief from symptoms such as wheezing and shortness of breath.
仅用于科研。不用于诊断过程。未经明确授权不得转售。